Dr. Andrew Inltekofer
Title of Grant: Elucidating and targeting IDH2 mutations in T cell lymphoma Description: Drugs that target mutant forms of the metabolic enzyme isocitrate dehydrogenase 2 (IDH2) are a promising appraoch to treat some cancers. The proposed research will uncover how mutant IDH2 causes T cell lymphoma and determine whether inhibiting mutant IDH2 offers an effective […]
Read more